
Trained in the science of measuring value, then spent years building it into products. An MS in Pharmaceutical Sciences with a concentration in pharmacoeconomics, the discipline of determining whether an intervention is worth what it costs, followed by strategy and product roles from Fortune 100 to early-stage.
Runs the working sessions and writes the analysis on every engagement.
